Monoclonal antibody against muramyl peptides
US9695231B2 · kind B2 · utility
3Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 2013 |
| Grant date | Jul 4, 2017 |
| Priority date | — |
| Expiry date | Nov 1, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4722
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is an isolated antibody or an antigen-binding fragment thereof. The antibody is capable of binding to a muramyl peptide, or a derivative or an analog or a salt thereof. The muramyl peptide comprises muramic acid and an amino acid selected from the group consisting of alanine, isoglutamine, glutamic acid, and a salt thereof. Also disclosed are methods of producing the antibody, compositions comprising the antibody, methods of treating using the antibody, uses of the antibody, methods of detecting muramyl peptide, an assay for detecting muramyl peptide, an antibacterial agent, hybridomas and kits.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.